January 7, 2015

Three supplement categories are really helping to drive the business today.

January 7, 2015

Pharmavite earlier this year launched a product that capitalizes on two current growth trends — immunity supplements and the gummy format. 

January 7, 2015

Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting such lung-specific diseases as influenza, pneumonia and tuberculosis.

January 7, 2015

Dietary supplementation represents big dollars in terms of the amount of healthcare costs saved by improving health outcomes and avoiding disease state ramifications.

January 5, 2015

The Consumer Healthcare Products Association thanked President Obama for signing the Designer Anabolic Steroid Control Act into law last month.

January 5, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the vitamins, minerals and supplements and diet aid categories, highlighting new products that are transforming OTC in this multi-page report.

January 5, 2015

Sam’s Club Pharmacies will host 10 free monthly health screenings nationwide in 2015 for members and non-members, covering a wide range of tests to manage and discover potential health issues.

December 30, 2014

Vertex Pharmaceuticals has announced that the Food and Drug Administration approved a supplemental new drug application for the use of Kalydeco (ivacaftor) in people with cystic fibrosis ages 6 years and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator gene.

December 22, 2014

Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.

December 17, 2014

Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.

December 16, 2014
December 15, 2014

Multicultural consumers are expected to be a key driver in strengthening pet ownership rates in America in the future, according to “Pet Population and Ownership Trends in the U.S.,” a recent report by market research publisher Packaged Facts.

December 12, 2014

The Council for Responsible Nutrition on Thursday welcomed the passage of the Designer Anabolic Steroid Control Act of 2014, a measure that will protect consumers from potentially dangerous anabolic steroids falsely marketed as dietary supplements.

December 12, 2014

Sanofi Pasteur announced that the FDA approved the supplemental biologics license application for Fluzone Intradermal Quadrivalent vaccine.

December 11, 2014

The Food and Drug Administration on Wednesday approved Gardasil 9 for the prevention of certain diseases caused by nine types of human papillomavirus.

December 5, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in analgesics, vitamins, allergy/cold/sinus medications, and incontinence, highlighting new products that are transforming OTC in this multi-page report.

December 3, 2014

Thompson Brands on Tuesday announced the launch of an improved formula for its Adora Calcium Supplement.

December 1, 2014

This flu season, Rexall has partnered with Amref Health Africa to launch “Shot For Shot,” a campaign committed to providing life-saving vaccinations to children that need it most.

November 25, 2014

Walgreens will donate the value of one pneumonia vaccine to The United Nations Foundation's Shot@Life for every pneumonia vaccine administered in its pharmacies between Nov. 28 and Dec. 2.

November 20, 2014

Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023. 

November 18, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

November 17, 2014

Ferndale Healthcare on Friday announced that its Heliocare brand has committed to support Vitamin Angels and Walgreens in their effort to help at-risk populations in need.

November 17, 2014

Earlier this year iHealth Lab launched iHealth Align, a mobile blood-glucose monitor that plugs directly into a smartphone, and displays and stores readings using the iHealth Gluco-Smart app.